|
|
4698 Willow Road
Pleasanton, CA 94588 USA
phone:(925) 474-2500
fax:(925) 474-2599
|
|
| Symbol |
Private |
| Founded |
2005 |
| Employees |
|
|
|
| www.zeltiq.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Non-Invasive Fat Layer Reduction |
|
| Management |
| Mitchell E. Levinson, President and Chief Executive Officer; John W. Allison, Ph.D., Vice President of Research, Development and Clinical Affairs; Edward A. Ebbers, Vice President of Marketing and Sales; Donald V. Johnson, Vice President of Operations, Quality, and Regulatory Affairs; William C. Revelos
Vice President and General Counsel |
| |
|
|
| |
|
| Keywords |
| Aesthetics, Surgery, Body Shaping, Cryolipolysis |
|
|
|
| Description |
|
Zeltiq Aesthetics, founded in 2005, is a science-based medical device company dedicated to the development and commercialization of non-invasive procedures to help patients achieve cosmetic improvements by reducing or modifying unwanted fat. |
|
| Technology / Differentiation |
| Cryolipolysis is the non-invasive cooling of fat cells to induce lipolysis (the breakdown of fat) without damage to other tissue types. This novel technology is designed to enable safe reduction of fat tissue near nerves, muscle and bones. Cryolipolysis penetrates deepest in thick fat areas, tapering to less effect in leaner areas, which causes natural body sculpting. |
|
|
| Status |
| Zeltiq Aesthetics has licensed all commercial development rights from Massachusetts General Hospital and is continuing evaluation and development with leading aesthetic research centers. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members